Regulating lipid levels via the zmax1 or hbm gene
Details for Australian Patent Application No. 2001269712 (hide)
International Classifications
Event Publications
9 October 2003 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 01 Sep 2003
1 June 2006 Change of Name(s) of Applicant(s), Section 104
Creighton University; Genome Therapeutics Corporation The name of the applicant has been changed to Creighton University; Oscient Pharmaceuticals Corporation 2003
22 February 2007 Application Accepted
Published as AU-B-2001269712
21 June 2007 Standard Patent Sealed
22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser